Mapping technological capabilities into product markets and competitive advantage : the case of cholesterol drugs
By: AFUAH, Allan
.
Material type: ![materialTypeLabel](/opac-tmpl/lib/famfamfam/AR.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
Item type | Current location | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Periódico | Biblioteca Graciliano Ramos | Periódico | Not for loan |
While a lot of attention has been paid to those characteristics of capabilities that give firms a competitive advantage, a lot less attention has been given to supporting empirical evidence and to the deployment of these capabilities. This paper presents a model for mapping firm capabilities into customer value and competitive advantage in different markets. With empirical evidence from cholesterol drugs, I illustrate how he model can be used to estimate customer value and competitive advantage from technological capabilities
There are no comments for this item.